Preclinical and Clinical Activity of Anti-DLL4 (Demcizumab) in Combination with Gemcitabine Plus nab-Paclitaxel in Pancreatic Cancer Manuel Hidalgo*, Antonio Cubillo*, Robert Stagg**, Jakob Dupont**, Wan-Ching Yen**, Tim

First Page		Document Content
Date: 2014-11-19 14:29:44		Preclinical and Clinical Activity of Anti-DLL4 (Demcizumab) in Combination with Gemcitabine Plus nab-Paclitaxel in Pancreatic Cancer Manuel Hidalgo, Antonio Cubillo, Robert Stagg, Jakob Dupont, Wan-Ching Yen**, Tim Add to Reading List Source URL: s3.amazonaws.com Download Document from Source Website File Size: 681,81 KB Share Document on Facebook